Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : RETA    crawled time : 16:00    save search

Over 100 Patients Now Enrolled in CNS Pharmaceuticals’ (NASDAQ: CNSP) Potentially Pivotal Study Evaluating Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
Published: 2023-04-10 (Crawled : 16:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: -1.23% H: 1.81% C: 1.25%
CNSP | News | $0.2002 -4.67% -4.9% 76K twitter stocktwits trandingview |
Health Technology
| | O: -4.79% H: 8.16% C: 4.9%

berubicin treatment 100 glioblastoma study
Extremely Robust COVID-19 Clinical Trial Pipeline With 420+ Key Companies Expected to Change the Pace of the COVID-19 Treatment
Published: 2022-11-08 (Crawled : 16:00) - prnewswire.com
XNCR | $19.05 3.7% 3.57% 760K twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 12.8% C: 8.43%
VRNA | $15.21 -2.44% -2.5% 320K twitter stocktwits trandingview |
Health Technology
| | O: 1.35% H: 2.31% C: 1.09%
RETA | $172.36 0.02% 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: 3.15% H: 18.92% C: 11.92%
KNSA | $17.85 0.96% 0.95% 370K twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 0.26% C: -3.81%

covid-19 treatment companies change expected trial
Global Diabetic Nephropathy Treatment Market to Reach $3.5 Billion by 2026
Published: 2021-10-06 (Crawled : 16:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: -0.96%
PFE | News 4 | $26.27 -0.19% -0.15% 23M twitter stocktwits trandingview |
Health Technology
| | O: -0.61% H: 0.33% C: -0.1%
NVS | News | $98.35 1.1% 0.0% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.71% C: 0.5%
ABT | News | $106.89 -0.65% -0.22% 5.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.7% C: 0.64%
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.87% H: 0.8% C: 0.63%
RETA | $172.36 0.02% 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.77% H: 1.42% C: -1.5%

treatment nephropathy diabetic diabetes
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.